Research coauthored by RTI-Health Solutions researcher Alejandro Vanegas will be presented at the International Symposium on Merkel Cell Carcinoma (ISMCC 2022).
Bhatia S, Nghiem P, Veeranki SP, Vanegas A, Lachance K, Tachiki L, Chiu K, Boller E, Bharmal M. Real-world clinical outcomes among patients with advanced Merkel cell carcinoma treated with avelumab in academic medical centers in the United States. Presentation to be given at the International Symposium on Merkel Cell Carcinoma (ISMCC 2022); April 25, 2022.
